Episode 16 | Global Health Dialogues With Princess Dina And Dr Garo Armen El Clasico 2026 [KZrvmN4Affd]

In this episode, Princess Dina sits down with Dr. Garo Armen, Chairman and CEO of Agenus, to explore the promise and limits of immunotherapy. But beyond the science, this conversation confronts a critical question: Why do life-saving innovations often take indianapolis weather yearssometimes decadesto reach the patients who need them most? Together, they examine how regulatory complexity, bureaucratic processes, and fragmented health systems can unintentionally delay access to new treatmentsturning scientific progress into a slower, uneven reality for patients around the world.

sunderland vs man united Topics cover:

00:00 INTRODUCTION

00:02 PERSONAL JOURNEY

00:05 WHEN HEAT AWAKENS

THE IMMUNE SYSTEM

00:10 TAKING THE LEAP TO

START AGENUS

00:13 HOW HAS AGENUS HARNESSED OUR

OWN IMMUNE SYSTEM TO FIGHT CANCER

00:19 ROLE OF COMBINATION THERAPIES

IN FIGHTING CANCER

00:24 VACCINE DEVELOPMENT

AGENUS ADJUVANT TECHNOLOGIES

00:28 WHY DOESNT IMMUNOTHERAPY

WORK FOR ALL CANCERS?

00:31COLD VS HOT TUMORS

00:36 ROLE OF AI

00:36 INHIBITING ROLE

OF REGULATIONS

00:38 LACK OF ACCESS AND EQUITY

CLINICAL TRIAL BIAS

00:39 ACCESS AND EQUITY

IN IMMUNOTHERAPY

00:44 ROLE OF MEDIA

00:44 RUSSIAN CANCER

VACCINE

00:49 PROMISE professor green OF PARASITIC DRUGS

IN CANCER TREATMENT

00:50 IMMUNOTHERAPY: WHERE ARE

WE ON THE JOURNEY?

00:53 BUILDING A BIOTECH STARTUP:

HOW HARD IS THE JOURNEY?

00:57 PRECISION WITHOUT EQUITY IS

NOT PROGRESS. IT IS PRIVILEGE.

00:59 WHAT WOULD IT TAKE TO CURE CANCER

IF NOTHING STOOD IN THE WAY?

01:01 RECAP and CLOSING

A powerful conversation at the intersection of science, truth, and justice.

---

Episode is presented by @OncoDailyTV

SUBSCRIBE to get the latest: @globalhealthdialogues

FOLLOW Global Health Dialogues

LinkedIn: @princessdinamired

X (Twitter): @GHDialogues

Instagram: @globalhealthdialogues

Facebook: @GlobalHealthDialoguesWithPrincess